Integral Health Asset Management, LLC Fate Therapeutics Inc Transaction History

Integral Health Asset Management, LLC

$850 Million
Q3 2024

A detailed history of Integral Health Asset Management, LLC transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Integral Health Asset Management, LLC holds 975,000 shares of FATE stock, worth $1.83 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

975,000

Previous 850,000 14.71%

Holding current value

$1.83 Million

Previous $2.79 Million 22.38%

% of portfolio

0.4%

Previous 0.27%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.12 - $5.57 $390,000 - $696,250	125,000 Added 14.71%	975,000 $3.41 Million
Q2 2024 Aug 14, 2024	BUY	$3.26 - $7.08 $2.12 Million - $4.6 Million	650,000 Added 325.0%	850,000 $2.79 Million
Q1 2024 May 15, 2024	SELL	$3.54 - $8.35 $2.48 Million - $5.85 Million	-700,000 Reduced 77.78%	200,000 $1.47 Million
Q4 2023 Feb 14, 2024	BUY	$1.65 - $3.94 $1.49 Million - $3.55 Million	900,000 New	900,000 $3.37 Million
Q1 2022 May 12, 2022	SELL	$29.67 - $60.28 $3.86 Million - $7.84 Million	-130,000 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$47.84 - $64.34 $1.67 Million - $2.25 Million	35,000 Added 36.84%	130,000 $7.61 Million
Q3 2021 Nov 12, 2021	BUY	$59.27 - $95.73 $889,050 - $1.44 Million	15,000 Added 18.75%	95,000 $5.63 Million
Q2 2021 Aug 30, 2021	SELL	$67.25 - $92.52 $5.38 Million - $7.4 Million	-80,000 Reduced 50.0%	80,000 $6.94 Million
Q2 2021 Aug 13, 2021	BUY	$67.25 - $92.52 $8.07 Million - $11.1 Million	120,000 Added 300.0%	160,000 $13.9 Million
Q1 2021 May 10, 2021	BUY	$72.16 - $117.4 $2.89 Million - $4.7 Million	40,000 New	40,000 $3.3 Million
Q4 2020 Feb 16, 2021	SELL	$38.09 - $100.95 $3.24 Million - $8.58 Million	-85,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$30.41 - $40.5 $456,150 - $607,500	15,000 Added 21.43%	85,000 $3.4 Million
Q2 2020 Aug 14, 2020	SELL	$20.21 - $35.23 $505,250 - $880,749	-25,000 Reduced 26.32%	70,000 $2.4 Million
Q1 2020 May 15, 2020	BUY	$17.28 - $31.88 $1.64 Million - $3.03 Million	95,000 New	95,000 $2.11 Million

Others Institutions Holding FATE

# of Institutions

175

Shares Held

115M

Call Options Held

53.7K

Put Options Held

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $182M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integral Health Asset Management, LLC with notifications on news.

Account

Integral Health Asset Management, LLC Fate Therapeutics Inc Transaction History